AIM ImmunoTech Inc.
AIM
$0.26
-$0.01-2.59%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 27.59% | -27.13% | -17.54% | 24.59% | 37.91% |
| Total Depreciation and Amortization | 0.00% | -20.37% | -1.82% | -5.17% | -9.38% |
| Total Amortization of Deferred Charges | -39.00% | 334.78% | -42.02% | 85.94% | -7.25% |
| Total Other Non-Cash Items | -71.13% | 383.09% | 33.33% | -29.17% | -6.90% |
| Change in Net Operating Assets | -292.80% | 94.63% | -397.06% | -0.89% | -44.17% |
| Cash from Operations | -36.91% | 60.90% | -231.74% | 35.15% | 40.30% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.05% | -132.09% | -60.74% | -16.04% | -75.76% |
| Cash from Investing | 61.05% | -132.09% | -60.74% | -16.04% | -75.76% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 6,486.67% | -84.09% | 1,962.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -76.43% | 1,637.69% | -- | -- | -- |
| Cash from Financing | 105.48% | -59.14% | 1,774.37% | -46.21% | -36.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 343.73% | -65.90% | 543.36% | 47.45% | -202.16% |